PTPRC and hepatocellular carcinoma: Overall, we identified two types of Bregs in the liver (CD19+B220+CD5+CD1d+ and CD19-B220+CD5+CD1d-), which exhibit an inhibitory phenotype characterized by high expression of PD-L1 and IL-10 in aggressive murine HCC/CaMIN.